{"id": "batch_req_67df5fce74b08190b001e158c36c718b", "custom_id": "syn4939874", "response": {"status_code": 200, "request_id": "701d3a9db0629e83b2e4974a413fbb4e", "body": {"id": "chatcmpl-BE49kMoG4GVJF8RcXdDpKJBbqN56a", "object": "chat.completion", "created": 1742692268, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the provided project and table summaries, here's the curated dataset metadata following the JSON schema specified:\n\n```json\n[\n  {\n    \"title\": \"NFOSI-WES-To-Process-2024-03\",\n    \"creator\": \"Sara Gosline, Xindi Guo\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Whole Exome Sequencing\", \"WES\", \"BAM files\"],\n    \"dataType\": [],\n    \"studyId\": \"syn4939874\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"alternateName\": \"Whole Exome Sequencing Data\",\n    \"conditionsOfAccess\": \"Contact the data contributor for access permissions.\",\n    \"contributor\": [\"Sara Gosline\", \"Xindi Guo\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"Whole exome sequencing data files in BAM format for neurofibromatosis-related research.\",\n    \"datePublished\": 2024\n  },\n  {\n    \"title\": \"Selected pNF cell line Kallisto output\",\n    \"creator\": \"Sara Gosline\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Kallisto\", \"RNASeq\", \"Cell Line\", \"Plexiform Neurofibroma\"],\n    \"dataType\": [],\n    \"studyId\": \"syn4939874\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"alternateName\": \"pNF Cell Line RNASeq Kallisto Output\",\n    \"conditionsOfAccess\": \"Contact the data contributor for access permissions.\",\n    \"contributor\": [\"Sara Gosline\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"Kallisto quantification outputs for pNF cell line RNA sequencing datasets.\",\n    \"datePublished\": 2024\n  },\n  {\n    \"title\": \"pNF Cell Line RNA-seq (NFOSIprocessing-2022-04-18)\",\n    \"creator\": \"Unknown\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNASeq\", \"geneExpression\", \"Plexiform Neurofibroma\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn4939874\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"countryOfOrigin\": [\"USA\"],\n    \"contributor\": [],\n    \"species\": [\"Homo sapiens\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 11,\n    \"specimenCount\": 11,\n    \"description\": \"RNA-seq data of pNF cell line samples focusing on gene expression analysis for neurofibromatosis research.\",\n    \"datePublished\": 2022\n  }\n]\n```\n\nNote:\n- Some fields like `dataType` and certain specific details were omitted or marked as empty due to the lack of explicit information in the table summaries.\n- The `creator` for the third dataset was marked as \"Unknown\" since the specific creator was not provided.\n- For logical consistency, the access type was assumed to be \"Controlled Access\" for derived cells/data intended for research use with possible limitations.\n", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5096, "completion_tokens": 738, "total_tokens": 5834, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fce8630819086e0ac389734aad7", "custom_id": "syn8016650", "response": {"status_code": 200, "request_id": "58600aa33719be8341ba90cf0bbe69ec", "body": {"id": "chatcmpl-BE49k4v6HbkzhEiqtAwA1iizYFncg", "object": "chat.completion", "created": 1742692268, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Here is the curated dataset metadata in JSON format:\n\n```json\n[\n  {\n    \"title\": \"ATP hydrolisis rate\",\n    \"creator\": \"Andrea Rasola\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"ATPase activity\", \"Metabolism\", \"TRAP1\", \"Neurofibroma\", \"Cancer\"],\n    \"dataType\": [\"clinical\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"ATPase activity assay\"],\n    \"species\": [\"Homo sapiens\"],\n    \"tumorTypesPresent\": [\"NF1\"]\n  },\n  {\n    \"title\": \"CRC\",\n    \"creator\": \"Andrea Rasola\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Calcium retention capacity\", \"Mitochondrial function\", \"TRAP1\", \"Neurofibroma\"],\n    \"dataType\": [\"clinical\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"calcium retention capacity assay\"],\n    \"species\": [\"Homo sapiens\"],\n    \"tumorTypesPresent\": [\"NF1\"]\n  },\n  {\n    \"title\": \"NADH dehydrogenase activity\",\n    \"creator\": \"Andrea Rasola\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NADH dehydrogenase\", \"Respiratory chain\", \"TRAP1\"],\n    \"dataType\": [\"clinical\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"]\n  },\n  {\n    \"title\": \"OCR and ECAR\",\n    \"creator\": \"Andrea Rasola\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Oxygen consumption rate\", \"Glycolysis\", \"Metabolic assay\", \"TRAP1\"],\n    \"dataType\": [\"clinical\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"oxygen consumption assay\"],\n    \"species\": [\"Homo sapiens\", \"Danio rerio\"],\n    \"tumorTypesPresent\": [\"NF1\"]\n  },\n  {\n    \"title\": \"SDH activity\",\n    \"creator\": \"Andrea Rasola\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Sorbitol dehydrogenase\", \"Metabolic enzymes\", \"Neurofibromatosis\", \"TRAP1\"],\n    \"dataType\": [\"clinical\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"sorbitol dehydrogenase activity level assay\"],\n    \"species\": [\"Mus musculus\", \"Homo sapiens\", \"Danio rerio\"],\n    \"tumorTypesPresent\": [\"NF1\", \"Malignant Peripheral Nerve Sheath Tumor\"]\n  },\n  {\n    \"title\": \"SDS and BN-PAGE\",\n    \"creator\": \"Andrea Rasola\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Protein assays\", \"TRAP1\", \"Electrophoresis\"],\n    \"dataType\": [\"clinical\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"SDS-PAGE\", \"blue native PAGE\", \"gel filtration chromatography\"],\n    \"species\": [\"Homo sapiens\"],\n    \"tumorTypesPresent\": [\"NF1\"]\n  }\n]\n```\n\nPlease note that the metadata has been curated according to the provided information, with some fields omitted when data were incomplete or unavailable. Let me know if further adjustments are needed or if you have specific aspects you want to be addressed in the dataset metadata.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 7210, "completion_tokens": 934, "total_tokens": 8144, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcea6cc8190bb50524088153c29", "custom_id": "syn5610418", "response": {"status_code": 200, "request_id": "39f4fc4c6791ea9ad026ed7ed877b6fb", "body": {"id": "chatcmpl-BE49rvbpjF5prXadHl1quAOj5Y248", "object": "chat.completion", "created": 1742692275, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the provided information, here is the high-quality dataset metadata in JSON format for the table \"Synodos NF1 Patient WES Data (GSE145064)\":\n\n```json\n[\n    {\n        \"title\": \"Synodos NF1 Patient WES Data (GSE145064)\",\n        \"creator\": \"Unknown\",  // Specifying \"Unknown\" because the contributor is not mentioned\n        \"accessType\": \"Public Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"RNA-seq\",\n            \"Neurofibromatosis type 1\",\n            \"Plexiform Neurofibroma\",\n            \"Malignant Peripheral Nerve Sheath Tumor\",\n            \"geneExpression\",\n            \"Homo sapiens\"\n        ],\n        \"dataType\": [\n            \"geneExpression\"\n        ],\n        \"studyId\": \"syn5610418\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"CTF\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 15,\n        \"specimenCount\": 46,\n        \"countryOfOrigin\": [\n            \"Unknown\"  // Country of origin is not mentioned\n        ],\n        \"description\": \"This dataset includes RNA-seq data for 15 individuals with Neurofibromatosis type 1, comprising 46 specimens. The data encapsulates tumor types such as Plexiform Neurofibroma and Malignant Peripheral Nerve Sheath Tumor. The files are in fastq format.\",\n        \"manifestation\": [\n            \"Plexiform Neurofibroma\",\n            \"Malignant Peripheral Nerve Sheath Tumor\"\n        ],\n        \"measurementTechnique\": [\n            \"RNA-seq\"\n        ],\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    }\n]\n```\n\n### Notes:\n- The \"creator\" is unknown from the provided information. It's advisable to replace this placeholder with the actual name if available.\n- The \"countryOfOrigin\" field is added with \"Unknown\" to indicate the absence of specific information. This can be omitted if you prefer excluding unknown data.\n- I've assumed public access based on typical practices, but if this does not reflect the actual situation, please adjust or provide correct information regarding the access type.\n- The \"includedInDataCatalog\" is filled based on the typical catalog URL provided in your JSON schema. Adjust if there are specific catalogs this data is associated with.\n- Other metadata fields were filled with assumptions based on your dataset schema where information was missing.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4468, "completion_tokens": 541, "total_tokens": 5009, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcec4088190914617e72400ba6c", "custom_id": "syn8016599", "response": {"status_code": 200, "request_id": "4b993ee1da99b5386414331aeb4aba0b", "body": {"id": "chatcmpl-BE49v9RIBjKcucNeZF5Rfvl712Iu1", "object": "chat.completion", "created": 1742692279, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the provided project and table information, here is the curated dataset metadata in JSON format that aligns with your specified schema:\n\n```json\n[\n    {\n        \"title\": \"Kinome Data\",\n        \"creator\": \"Stephanie Bouley\",\n        \"accessType\": \"Open Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"Kinome\", \"MIB/MS\", \"NF1\", \"Proteomics\"],\n        \"dataType\": [\"kinomics\"],\n        \"studyId\": \"syn8016599\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"NTAP\"],\n        \"description\": \"This dataset contains kinome data of NF1-deficient Schwann cells obtained through MIB/MS assays. It aims to reveal kinomic changes in cells deficient in neurofibromin.\",\n        \"species\": [\"Homo sapiens\"],\n        \"contributors\": [\"Stephanie Bouley\"],\n        \"measurementTechnique\": \"MIB/MS\",\n        \"fileFormatsPresent\": [\"excel\"],\n        \"datePublished\": 20231130,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"NFOSI RNASeq To Process 2023-14-03\",\n        \"creator\": \"Stephanie Bouley\",\n        \"accessType\": \"Open Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"RNA-seq\", \"NF1\", \"GeneExpression\"],\n        \"dataType\": [\"geneExpression\"],\n        \"studyId\": \"syn8016599\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"NTAP\"],\n        \"description\": \"A raw RNASeq dataset intended for future processing to analyze gene expression related to NF1-deficient Schwann cells.\",\n        \"contributors\": [\"Stephanie Bouley\"],\n        \"fileFormatsPresent\": [\"fastq\"],\n        \"datePublished\": 20231130,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"Proteomics Data\",\n        \"creator\": \"Stephanie Bouley\",\n        \"accessType\": \"Open Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"Proteomics\", \"TMT quantitation\", \"NF1\"],\n        \"dataType\": [\"kinomics\"],\n        \"studyId\": \"syn8016599\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"NTAP\"],\n        \"description\": \"Proteomics dataset of NF1-deficient Schwann cells obtained through TMT quantitation, examining the total proteome and phosphoproteome.\",\n        \"species\": [\"Homo sapiens\"],\n        \"contributors\": [\"Stephanie Bouley\"],\n        \"measurementTechnique\": \"TMT quantitation\",\n        \"fileFormatsPresent\": [\"excel\"],\n        \"datePublished\": 20231130,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"RNAseq Raw Data\",\n        \"creator\": \"Stephanie Bouley\",\n        \"accessType\": \"Open Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"RNA-seq\", \"NF1\", \"GeneExpression\"],\n        \"dataType\": [\"geneExpression\"],\n        \"studyId\": \"syn8016599\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"NTAP\"],\n        \"description\": \"Raw RNA-seq data from NF1-deficient Schwann cells, intended for analysis of gene expression changes.\",\n        \"species\": [\"Homo sapiens\"],\n        \"contributors\": [\"Stephanie Bouley\"],\n        \"measurementTechnique\": \"RNA-seq\",\n        \"diagnosesPresent\": [\"Neurofibromatosis type 1\"],\n        \"fileFormatsPresent\": [\"fastq\"],\n        \"datePublished\": 20231130,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    }\n]\n```\n\n**Note:**\n- For fields like `individualCount`, `specimenCount`, `diagnosisPresent`, and `tumorTypesPresent` whose information is not provided or is marked as '?', these are currently omitted as per the schema.\n- You may add or modify details based on further information available, especially for fields marked as mandatory by the schema.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5931, "completion_tokens": 923, "total_tokens": 6854, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fced49881909d82caeae8d01421", "custom_id": "syn4939910", "response": {"status_code": 200, "request_id": "4fb0cda7b972c19c7625f81d3343798c", "body": {"id": "chatcmpl-BE49rmNuJbPemCnrhTHnLTI1Ya3q8", "object": "chat.completion", "created": 1742692275, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Here is a JSON array of high-quality dataset metadata based on the given information:\n\n```json\n[\n  {\n    \"title\": \"Copy Number Variant - CNVkit\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"CNVkit\", \"Copy Number Variant\", \"Genomic Alteration\"],\n    \"dataType\": [\"CopyNumberVariants\"],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"This dataset generated using CNVkit contains copy number variants data for Neurofibromatosis Type 1 (NF1) research.\",\n    \"dataUseModifiers\": [\"General Research Use\"]\n  },\n  {\n    \"title\": \"Germline Genomic Variants - DeepVariant Pipeline\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"DeepVariant\", \"Genomic Variants\", \"VCF\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"This dataset contains germline genomic variants processed using the DeepVariant Pipeline for NF1 research.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"dataUseModifiers\": [\"General Research Use\"]\n  },\n  {\n    \"title\": \"Germline Genomic Variants - FreeBayes Pipeline\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"FreeBayes\", \"Genomic Variants\", \"VCF\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Germline genomic variants detected in NF1 patients using the FreeBayes Pipeline.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"dataUseModifiers\": [\"General Research Use\"]\n  },\n  {\n    \"title\": \"Germline Genomic Variants - Mutect2 Pipeline\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Mutect2\", \"Genomic Variants\", \"VCF\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Data includes germline genomic variants in NF1 patients processed through the Mutect2 Pipeline.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"dataUseModifiers\": [\"General Research Use\"]\n  },\n  {\n    \"title\": \"Germline Genomic Variants - Strelka Pipeline\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Strelka\", \"Genomic Variants\", \"VCF\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Strelka Pipeline generated germline genomic variants in NF1 patients.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"dataUseModifiers\": [\"General Research Use\"]\n  },\n  {\n    \"title\": \"Metadata\",\n    \"creator\": \"Benjamin Johnson\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Metadata\", \"Chromatin Activity\", \"Neurofibromatosis\"],\n    \"dataType\": [\"chromatinActivity\"],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Detailed metadata related to chromatin activity studies in Neurofibromatosis Type 1.\",\n    \"tumorTypes\": [\"Cutaneous Neurofibroma\"],\n    \"dataUseModifiers\": [\"General Research Use\"]\n  },\n  {\n    \"title\": \"NFOSI-RNASeq-To-Process-2023-14-03\",\n    \"creator\": \"Steven Angus\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NFOSI\", \"RNASeq\", \"To Process\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"RNA-Seq data from NFOSI awaiting processing for NF1 research.\",\n    \"dataUseModifiers\": [\"General Research Use\"]\n  },\n  {\n    \"title\": \"NFOSIprocessing-2022-26-04\",\n    \"creator\": \"Matt\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NFOSI\", \"Processing\", \"Genomic Variants\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"tumorTypes\": [\"Plexiform Neurofibroma\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Dataset containing genomic variants derived from whole genome sequencing in NF1 patients.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"dataUseModifiers\": [\"General Research Use\"]\n  },\n  {\n    \"title\": \"Processed_beta_matrix\",\n    \"creator\": \"Benjamin Johnson, Sara Gosline\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Processed Beta Matrix\", \"Methylation\", \"Chromatin Activity\"],\n    \"dataType\": [\"chromatinActivity\"],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Processed beta matrices providing insights into chromatin activity in Neurofibromatosis Type 1.\",\n    \"dataUseModifiers\": [\"General Research Use\"]\n  },\n  {\n    \"title\": \"Raw_CNF_PNF_EPIC_idats\",\n    \"creator\": \"Benjamin Johnson\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Raw idats\", \"Cutaneous Neurofibroma\", \"Plexiform Neurofibroma\"],\n    \"dataType\": [\"chromatinActivity\"],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"tumorTypes\": [\"Cutaneous Neurofibroma\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Raw methylation EPIC idat files from CNF and PNF samples.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 38,\n    \"specimenCount\": 60,\n    \"dataUseModifiers\": [\"General Research Use\"]\n  },\n  {\n    \"title\": \"Van Andel - RNAseq and WXS\",\n    \"creator\": \"Steven Angus, Matt\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Van Andel\", \"RNAseq\", \"Whole Genome Sequencing\"],\n    \"dataType\": [\"geneExpression\", \"genomicVariants\"],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"tumorTypes\": [\"Plexiform Neurofibroma\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"A comprehensive dataset containing RNAseq and whole genome sequencing data for NF1 research.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"specimenCount\": 11,\n    \"dataUseModifiers\": [\"General Research Use\"]\n  },\n  {\n    \"title\": \"Whole Exome Sequencing of Mouse Samples\",\n    \"creator\": \"Megan Bowman\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Whole Exome Sequencing\", \"Mouse Samples\", \"Genomic Variants\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"tumorTypes\": [\"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Exome sequencing data from mouse models to investigate genomic variants relevant to MPNST in NF1 research.\",\n    \"species\": [\"Mus musculus\"],\n    \"individualCount\": 2,\n    \"specimenCount\": 7,\n    \"dataUseModifiers\": [\"General Research Use\"]\n  }\n]\n```\n\nThis JSON object provides metadata for each dataset according to the provided schema and available information. If certain fields were unknown or unspecified in the supplied data, I have left those out or marked them with placeholders where applicable, such as with the default license as \"UNKNOWN.\" If needed, further details can be filled in with more specific information about each dataset.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 7184, "completion_tokens": 2059, "total_tokens": 9243, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcee6ec819082ce4b9c5c08832f", "custom_id": "syn11374353", "response": {"status_code": 200, "request_id": "0ba523268187ba44c7f6ff0fe071c4dd", "body": {"id": "chatcmpl-BE49oA0irx9fzkGBIE1Fn4HuKLEdO", "object": "chat.completion", "created": 1742692272, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the provided data summaries and schema, here is a JSON metadata output for the datasets:\n\n```json\n[\n  {\n    \"title\": \"12 month deliverables\",\n    \"creator\": \"Bernat Gel Moreno\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"whole exome sequencing\", \"Homo sapiens\", \"Neurofibromatosis type 1\", \"cutaneous neurofibroma\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn64954755\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Dataset includes whole exome sequencing data related to cutaneous neurofibromas, focusing on genomic variants.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 10,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"18 month deliverables\",\n    \"creator\": \"Bernat Gel Moreno, Christina Parry\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"Homo sapiens\", \"Neurofibromatosis type 1\", \"cutaneous neurofibroma\", \"gene expression\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn64954756\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Included are RNA-seq datasets with gene expression data associated with cutaneous neurofibromas.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 13,\n    \"specimenCount\": 28,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"24 month deliverables\",\n    \"creator\": \"Bernat Gel Moreno\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"co-culture\", \"cutaneous neurofibroma\", \"interactions\"],\n    \"dataType\": [],\n    \"studyId\": \"syn64954757\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Data focusing on co-culture interactions within cutaneous neurofibromas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"36 month deliverables\",\n    \"creator\": \"Bernat Gel Moreno, Helena Mazuelas\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Luminex\", \"Experimental Description\", \"EdU assay\"],\n    \"dataType\": [],\n    \"studyId\": \"syn64954758\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"This dataset includes various assays and experimental data pertaining to cutaneous neurofibromas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"6 month deliverables\",\n    \"creator\": \"Bernat Gel Moreno\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"mutations\", \"analysis\", \"cutaneous neurofibroma\"],\n    \"dataType\": [],\n    \"studyId\": \"syn64954759\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Excel sheet with mutation analysis data related to cutaneous neurofibromas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Gene Expression Quantification from RNA-seq\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"gene expression\", \"quantification\", \"cutaneous neurofibroma\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn51930741\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [],\n    \"description\": \"Quantification for gene expression from RNA-seq data of cutaneous neurofibromas.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 13,\n    \"specimenCount\": 28,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NF-OSI-processed-data\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"aligned reads\", \"gene expression\", \"processed data\"],\n    \"dataType\": [\"geneExpression\", \"AlignedReads\"],\n    \"studyId\": \"syn64954760\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"This dataset contains processed RNA-seq data, including aligned reads and gene expression of cutaneous neurofibromas.\",\n    \"series\": \"NF-OSI Processed Data\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 13,\n    \"specimenCount\": 28,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NFOSI-RNASeq-To-Process-2023-14-03\",\n    \"creator\": \"Bernat Gel Moreno\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"to process\", \"raw data\"],\n    \"dataType\": [],\n    \"studyId\": \"syn51198956\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [],\n    \"description\": \"RNA-seq raw data pending processing related to cutaneous neurofibromas.\",\n    \"species\": [\"Homo sapiens\"],\n    \"specimenCount\": 28,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NFOSI-WES-To-Process-2024-03\",\n    \"creator\": \"Bernat Gel Moreno\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"WES\", \"to process\", \"raw data\" ],\n    \"dataType\": [],\n    \"studyId\": \"syn51199729\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [],\n    \"description\": \"Whole exome sequencing raw data pending processing.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```\n\nThis metadata description adheres closely to the JSON schema you provided, and I've filled in as many gaps as the available information allows. Please ensure any sensitive data remains protected with adequate access controls.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 6051, "completion_tokens": 1560, "total_tokens": 7611, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcef77081908ae30e1d707fd2d0", "custom_id": "syn21650484", "response": {"status_code": 200, "request_id": "1f7eddd20110ad84a10c01527d680793", "body": {"id": "chatcmpl-BE49lOSx5PpryTJpA1sGcBJHTK0pH", "object": "chat.completion", "created": 1742692269, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Here is the high-quality dataset metadata for the table provided, formatted according to the given JSON schema:\n\n```json\n[\n  {\n    \"title\": \"Bulk RNA Sequencing Donor RGCs\",\n    \"creator\": \"Julia Oswald, Christina Parry\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RGC Transplantation\",\n      \"stem cells\",\n      \"RNA sequencing\",\n      \"Mus musculus\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21650484\",\n    \"diseaseFocus\": [\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"alternateName\": \"Stem cell-derived RGC transplantation study\",\n    \"description\": \"This dataset contains bulk RNA sequencing data from murine retinal ganglion cells (RGCs) used in transplantation strategies, involving assays such as targeted exome sequencing. Data exploration focuses on improving RGC survival and integration.\",\n    \"contributor\": [\n      \"Julia Oswald\",\n      \"Christina Parry\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"specimenCount\": 2,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"measurementTechnique\": \"targeted exome sequencing\",\n    \"datePublished\": 2023,\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```\n\nThis metadata captures key details from the project and table summaries, fulfilling the requirements of the given JSON schema.\n", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4672, "completion_tokens": 339, "total_tokens": 5011, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcf07348190842d21bb0f5aa802", "custom_id": "syn7231973", "response": {"status_code": 200, "request_id": "2ee2afaad24234f197baca1d3eaabd4d", "body": {"id": "chatcmpl-BE49kcTPglfVrJ60lw3u9RnqquSFa", "object": "chat.completion", "created": 1742692268, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Here is the high-quality dataset metadata for the tables specified in the project:\n\n```json\n[\n  {\n    \"title\": \"Exome\",\n    \"creator\": \"Bernat Gel Moreno\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Whole Exome Sequencing\",\n      \"Genomic Variants\",\n      \"Plexiform Neurofibroma\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn7231973\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Exome sequencing dataset with genomic variants from Homo sapiens samples with a focus on Plexiform Neurofibroma associated with Neurofibromatosis type 1.\",\n    \"contributor\": [\n      \"Bernat Gel Moreno\"\n    ],\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 9,\n    \"specimenCount\": 35,\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"datePublished\": 2023,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NFOSI-WES-To-Process-2023-15-03\",\n    \"creator\": \"Bernat Gel Moreno\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Whole Exome Sequencing\",\n      \"Genomic Variants\",\n      \"Plexiform Neurofibroma\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn7231973\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Dataset intended for processing, related to whole exome sequencing data primarily involving Plexiform Neurofibroma in the context of Neurofibromatosis type 1.\",\n    \"contributor\": [\n      \"Bernat Gel Moreno\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"SNParray\",\n    \"creator\": \"Bernat Gel Moreno\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"SNP Array\",\n      \"Genomic Variants\",\n      \"Plexiform Neurofibroma\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn7231973\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"SNP array data focusing on the genomic variants found in Homo sapiens samples associated with Plexiform Neurofibroma and Neurofibromatosis type 1.\",\n    \"contributor\": [\n      \"Bernat Gel Moreno\"\n    ],\n    \"measurementTechnique\": \"SNP array\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 23,\n    \"specimenCount\": 40,\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"datePublished\": 2023,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```\n\nThis metadata provides a comprehensive and consistent description of the datasets adhering to the provided schema, effectively supporting search and discovery operations.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4953, "completion_tokens": 805, "total_tokens": 5758, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcf187c81908815629c0a733948", "custom_id": "syn23651229", "response": {"status_code": 200, "request_id": "73f87877902f2579ed50348d4d5a04a7", "body": {"id": "chatcmpl-BE49qPDQEHX8OTn7lsmHDVOWpJaHd", "object": "chat.completion", "created": 1742692274, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the provided information, here is the curated dataset metadata for the tables within the project:\n\n```json\n[\n  {\n    \"title\": \"Copy Number Variant - CNVkit\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Copy Number Variants\", \"Whole Genome Sequencing\", \"NF1\", \"MPNST\", \"Plexiform Neurofibroma\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NIH-NCI\", \"Independent\"],\n    \"description\": \"Ultra-low-pass whole genome sequencing using CNVkit to analyze copy number variants in plasma cfDNA from NF1 patients with plexiform neurofibroma and MPNST.\",\n    \"datePublished\": 2023,\n    \"individualCount\": 59,\n    \"specimenCount\": 117,\n    \"species\": [\"Homo sapiens\"],\n    \"tumor_types_present\": [\"Plexiform Neurofibroma\", \"Malignant Peripheral Nerve Sheath Tumor\", \"Not Applicable\"],\n    \"measurementTechnique\": \"whole genome sequencing\"\n  },\n  {\n    \"title\": \"Germline Genomic Variants - DeepVariant Pipeline\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Germline Variants\", \"Whole Genome Sequencing\", \"NF1\"],\n    \"dataType\": [\"GermlineVariants\"],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NIH-NCI\", \"Independent\"],\n    \"description\": \"Whole genome sequencing data processed using the DeepVariant pipeline to identify germline genomic variants in NF1 patients.\",\n    \"datePublished\": 2023,\n    \"individualCount\": 59,\n    \"specimenCount\": 117,\n    \"species\": [\"Homo sapiens\"],\n    \"file_formats_present\": [\"vcf\"],\n    \"measurementTechnique\": \"whole genome sequencing\"\n  },\n  {\n    \"title\": \"Germline Genomic Variants - FreeBayes Pipeline\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Germline Variants\", \"Whole Genome Sequencing\", \"NF1\"],\n    \"dataType\": [\"GermlineVariants\"],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NIH-NCI\", \"Independent\"],\n    \"description\": \"Whole genome sequencing data processed using the FreeBayes pipeline for germline variant detection in NF1 patients.\",\n    \"datePublished\": 2023,\n    \"individualCount\": 59,\n    \"specimenCount\": 117,\n    \"species\": [\"Homo sapiens\"],\n    \"file_formats_present\": [\"vcf\"],\n    \"measurementTechnique\": \"whole genome sequencing\"\n  },\n  {\n    \"title\": \"Germline Genomic Variants - Mutect2 Pipeline\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Germline Variants\", \"Whole Genome Sequencing\", \"NF1\"],\n    \"dataType\": [\"GermlineVariants\"],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NIH-NCI\", \"Independent\"],\n    \"description\": \"Germline genomic variant data generated using Mutect2 from whole genome sequencing of NF1 patients.\",\n    \"datePublished\": 2023,\n    \"individualCount\": 42,\n    \"specimenCount\": 90,\n    \"species\": [\"Homo sapiens\"],\n    \"file_formats_present\": [\"vcf\"],\n    \"measurementTechnique\": \"whole genome sequencing\"\n  },\n  {\n    \"title\": \"Germline Genomic Variants - Strelka Pipeline\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Germline Variants\", \"Whole Genome Sequencing\", \"NF1\"],\n    \"dataType\": [\"GermlineVariants\"],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NIH-NCI\", \"Independent\"],\n    \"description\": \"Strelka pipeline processing for germline genomic variants using whole genome sequencing data of NF1 patients.\",\n    \"datePublished\": 2023,\n    \"individualCount\": 59,\n    \"specimenCount\": 117,\n    \"species\": [\"Homo sapiens\"],\n    \"file_formats_present\": [\"vcf\"],\n    \"measurementTechnique\": \"whole genome sequencing\"\n  },\n  {\n    \"title\": \"NFOSIprocessing-2022-26-04\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Whole Genome Sequencing\", \"NF1\", \"MPNST\"],\n    \"dataType\": [\"clinical\", \"genomicVariants\"],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": \"UNKNOWN\",\n    \"description\": \"Whole genome sequencing data processed as part of the NFOSI processing project focusing on differentiating PN from MPNST in NF1 patients.\",\n    \"datePublished\": 2022,\n    \"individualCount\": 59,\n    \"specimenCount\": 117,\n    \"species\": [\"Homo sapiens\"],\n    \"tumor_types_present\": [\"Plexiform Neurofibroma\", \"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"measurementTechnique\": \"whole genome sequencing\"\n  },\n  {\n    \"title\": \"ULP Whole Genome Sequencing\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Whole Genome Sequencing\", \"NF1\", \"MPNST\", \"Clinical\"],\n    \"dataType\": [\"genomicVariants\", \"clinical\", \"metadata\"],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NIH-NCI\", \"Independent\"],\n    \"description\": \"Ultra-low-pass whole genome sequencing (ULP-WGS) data aimed at distinguishing MPNST from PN in NF1 patients, includes clinical metadata.\",\n    \"datePublished\": 2023,\n    \"individualCount\": 59,\n    \"specimenCount\": 117,\n    \"species\": [\"Homo sapiens\"],\n    \"tumor_types_present\": [\"Plexiform Neurofibroma\", \"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"file_formats_present\": [\"bam\", \"excel\"],\n    \"measurementTechnique\": \"whole genome sequencing\"\n  }\n]\n```\n\nThis metadata is created to be as comprehensive and accurate as possible using the information provided. Each dataset is assigned with relevant metadata tags, and where information is missing, terms like \"UNKNOWN\" are used to fill those gaps, especially for the license and incomplete fields.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5705, "completion_tokens": 1577, "total_tokens": 7282, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcf29388190a964deb0c15f3a58", "custom_id": "syn52740594", "response": {"status_code": 200, "request_id": "cae13dd6c504a7bb0f94e416d04fa26b", "body": {"id": "chatcmpl-BE49u32vO6Z6aqNd7x7bKGHwQAAGE", "object": "chat.completion", "created": 1742692278, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the provided information, here is the curated dataset metadata in JSON format:\n\n```json\n[\n  {\n    \"title\": \"Minnesota CCHMC Recombinetics Team Data\",\n    \"creator\": \"Sue Rathe, Jon Hawkinson, Kyle Williams, Mike Mason, Robert Allaway, Nasim Sanati, Sara Gosline\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"conventional MRI\",\n      \"RNA-seq\",\n      \"cell viability assay\",\n      \"Neurofibromatosis type 1\",\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\",\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn52740594\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Data from the Minnesota CCHMC Recombinetics team includes assays such as conventional MRI, RNA-seq, and cell viability assays. The dataset covers various diagnostic and tumor types focusing on NF1-related conditions.\",\n    \"contributor\": [\n      \"Sue Rathe\",\n      \"Jon Hawkinson\",\n      \"Kyle Williams\",\n      \"Mike Mason\",\n      \"Robert Allaway\",\n      \"Nasim Sanati\",\n      \"Sara Gosline\"\n    ],\n    \"species\": [\n      \"Sus scrofa\",\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 20,\n    \"specimenCount\": 21,\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor\"\n    ],\n    \"measurementTechnique\": [\n      \"conventional MRI\",\n      \"RNA-seq\",\n      \"cell viability assay\"\n    ],\n    \"datePublished\": 2023,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```\n\nThis JSON metadata aligns with the provided schema and includes relevant details from the project summary and tables for curation. If you have any additional information or specific modifications, feel free to reach out!", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4480, "completion_tokens": 487, "total_tokens": 4967, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcf39a881908b2965126abe3a63", "custom_id": "syn18904024", "response": {"status_code": 200, "request_id": "a7a8d323d6e8b07a7d64ce7b8af97c56", "body": {"id": "chatcmpl-BE49kR8F01pE9qRNh6MiLsKCPjvqn", "object": "chat.completion", "created": 1742692268, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the given project and table information, here is the curated dataset metadata in accordance with the provided JSON schema:\n\n```json\n[\n  {\n    \"title\": \"Optical Dopamine Monitoring with dLight1 in NF1 Model Mice\",\n    \"creator\": \"J. Elliott Robinson\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"dopaminergic neurotransmission\",\n      \"dLight1\",\n      \"mesolimbic circuitry\",\n      \"optogenetics\"\n    ],\n    \"dataType\": [\n      \"behavior process\",\n      \"electrophysiology\",\n      \"immunoassay\",\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn18904024\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"This dataset involves the study of dopaminergic neurotransmission using dLight1 in NF1 model mice. It explores the behavioral and electrophysiological data in response to various assays.\",\n    \"contributor\": [\n      \"J. Elliott Robinson\",\n      \"Gerard M. Coughlin\",\n      \"Acacia M. Hori\",\n      \"Elisha D. Mackey\",\n      \"Jounhong Ryan Cho\",\n      \"Zeynep Turan\",\n      \"Tommaso Patriarchi\",\n      \"Lin Tian\",\n      \"Viviana Gradinaru\"\n    ],\n    \"countryOfOrigin\": [\n      \"USA\"\n    ],\n    \"measurementTechnique\": [\n      \"contextual conditioning behavior assay\",\n      \"in vivo bioluminescence\",\n      \"whole-cell patch clamp\",\n      \"immunofluorescence\",\n      \"HPLC\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"individualCount\": null,\n    \"specimenCount\": null,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [],\n    \"datePublished\": 2023,\n    \"conditionsOfAccess\": \"Please contact the project PI for access.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```\n\n### Key Notes:\n- The `description` field provides a concise summary of the study.\n- `individualCount` and `specimenCount` are marked as `null` since these values were unavailable.\n- The `countryOfOrigin` is inferred based on the affiliations provided in the project information.\n- The `license` is marked as `UNKNOWN` due to the absence of specific license information.\n- The `datePublished` is estimated as 2023, assuming the data is recent.\n- The `conditionsOfAccess` are derived from the assumption that access would require contacting the project PI, given the controlled access classification.\n", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4694, "completion_tokens": 601, "total_tokens": 5295, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcf4a6881909fef27f80c26878b", "custom_id": "syn22267284", "response": {"status_code": 200, "request_id": "e18edf218819a1923f20b183dd2f7dbc", "body": {"id": "chatcmpl-BE49rtteRCMZKIfEZbK6DHWCoCB2X", "object": "chat.completion", "created": 1742692275, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the given information about the project \"Mapping and Identifying the Roles of Protein Glycosylation in Neurofibromatosis 1\" by Kevin Bruemmer at Stanford University, here are the curated metadata entries for each table/dataset in the project:\n\n```json\n[\n  {\n    \"title\": \"20201125-ipNF0.23 and ipnF05.5 O-glycosylation\",\n    \"creator\": \"Kevin Bruemmer\",\n    \"accessType\": \"Private Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"O-glycosylation\", \"proteomics\", \"mass spectrometry\", \"neurofibromatosis 1\", \"Homo sapiens\"],\n    \"dataType\": [\"proteomics\"],\n    \"studyId\": \"syn22267284\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"This dataset contains O-glycosylation proteomics data from ipNF0.23 and ipnF05.5 cells, analyzed using mass spectrometry.\",\n    \"contributor\": [\"Kevin Bruemmer\", \"Anh Nguyet Vu\"],\n    \"species\": [\"Homo sapiens\"],\n    \"specimenCount\": 2,\n    \"measurementTechnique\": \"mass spectrometry\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NF1 Proteomics\",\n    \"creator\": \"Kevin Bruemmer\",\n    \"accessType\": \"Private Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NF1\", \"proteomics\", \"mass spectrometry\", \"neurofibromatosis 1\", \"Homo sapiens\"],\n    \"dataType\": [\"proteomics\"],\n    \"studyId\": \"syn22267284\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"This dataset presents proteomics data derived from NF1 samples, analyzed using mass spectrometry.\",\n    \"contributor\": [\"Kevin Bruemmer\", \"Anh Nguyet Vu\"],\n    \"species\": [\"Homo sapiens\"],\n    \"specimenCount\": 2,\n    \"measurementTechnique\": \"mass spectrometry\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Neurofibromin Immunoprecipitation 20201123\",\n    \"creator\": \"Kevin Bruemmer\",\n    \"accessType\": \"Private Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"neurofibromin\", \"immunoprecipitation\", \"mass spectrometry\", \"proteomics\", \"Homo sapiens\"],\n    \"dataType\": [\"proteomics\"],\n    \"studyId\": \"syn22267284\",\n    \"diseaseFocus\": [],\n    \"funder\": [\"CTF\"],\n    \"description\": \"Proteomics dataset from neurofibromin immunoprecipitation studies conducted to investigate protein interactions.\",\n    \"contributor\": [\"Kevin Bruemmer\", \"Anh Nguyet Vu\"],\n    \"species\": [\"Homo sapiens\"],\n    \"specimenCount\": 1,\n    \"measurementTechnique\": \"mass spectrometry\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```\n\nIn this curation, I have used the available information to compile detailed descriptions, specify key contributors and methods, and provide essential metadata to facilitate potential discovery and use of these datasets. If any further details were available or additional context was required, additional properties could be filled in as needed.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4982, "completion_tokens": 782, "total_tokens": 5764, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcf5be8819080f56e609e015cad", "custom_id": "syn4939878", "response": {"status_code": 200, "request_id": "ff6023d8a2f093521f88fe19eb9541dd", "body": {"id": "chatcmpl-BE49yMWijFEt1vjbqRXqXg2meKBfA", "object": "chat.completion", "created": 1742692282, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the provided information, here is a JSON metadata description for the dataset in the specified schema:\n\n```json\n[\n  {\n    \"title\": \"PRO Reports\",\n    \"creator\": \"Sara Gosline\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Pediatric Quality of Life Inventory\", \"Neurofibromatosis Type 1\", \"PedsQL\", \"PRO\"],\n    \"dataType\": [\"surveyData\"],\n    \"studyId\": \"syn4939878\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"This dataset includes survey data from the Pediatric Quality of Life Inventory (PedsQL) Neurofibromatosis Type 1 Module, aimed at assessing quality of life in pediatric patients with NF1.\",\n    \"contributor\": [\"Nancy Swigonski, MD, MPH\", \"Kavitha Nutakki, MBBS, MPH\"],\n    \"measurementTechnique\": \"questionnaire\",\n    \"species\": [\"Homo sapiens\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"studyId\": \"syn4939878\"\n  }\n]\n```\n\n### Explanation:\n- **Access Type**: Determined as \"Controlled Access\" due to participant data involved and potential need for privacy considerations.\n- **Keywords**: Specific terms related to the PedsQL and the disease-focused module development.\n- **DataType**: Classified as \"surveyData\" based on the table's summary mentioning the usage of questionnaires.\n- **Study ID**: Matches the provided project ID.\n- **Creator**: Identified as Sara Gosline, based on the table's summary information.\n- **Funder**: Identified from the table's metadata.\n- **Contributors**: Includes both the Principal Investigator and Project Manager.\n- **Species**: Human, as per the summary.\n- **Measurement Technique**: The described technique is through questionnaires.\n- **Description**: Summarizes the core aim of the module testing for pediatric NF1 patients.\n  \nThe metadata is designed to provide a comprehensive view of the dataset while adhering strictly to the required fields and schema specifications.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4785, "completion_tokens": 467, "total_tokens": 5252, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcf6e348190bd65a32c7792b020", "custom_id": "syn11681835", "response": {"status_code": 200, "request_id": "ab2b1b5826a2e90824d0247544269269", "body": {"id": "chatcmpl-BE49qx9NLX2YN3ZIDRgjFRom50OnK", "object": "chat.completion", "created": 1742692274, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Here is the curated dataset metadata according to the provided information:\n\n```json\n[\n  {\n    \"title\": \"NF-OSI-processed-data\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"MPNST\", \"genomic approaches\", \"therapeutic development\", \"PRC2\", \"CDKN2A\", \"NF1\"],\n    \"dataType\": [],\n    \"studyId\": \"syn11681835\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"This dataset includes processed genomic data for the Malignant Peripheral Nerve Sheath Tumor (MPNST) project, focusing on inactivation of tumor suppressor pathways including NF1, CDKN2A, and PRC2.\",\n    \"creator\": \"NF Service\"\n  },\n  {\n    \"title\": \"NFOSI-RNASeq-To-Process-2023-14-03\",\n    \"creator\": \"Christina Parry\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"single-cell RNA-seq\", \"gene expression\", \"MPNST\", \"Neurofibromatosis type 1\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn11681835\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"countryOfOrigin\": [\"USA\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 41,\n    \"specimenCount\": 41,\n    \"description\": \"RNA sequencing data for 41 individuals diagnosed with Neurofibromatosis type 1 and Malignant Peripheral Nerve Sheath Tumor, using both bulk and single-cell RNA-seq techniques.\"\n  }\n]\n```\n\n### Notes:\n- The \"keywords\" and \"description\" fields are designed to reflect the core contents and focus of each dataset, based on the project summary.\n- \"Access Type\" is assumed to be \"Controlled Access\" for both datasets due to the sensitive nature of medical and genetic data.\n- Several fields are omitted from the first dataset due to missing information. If further details are provided, they should be included for a complete metadata description.\n- \"Country of Origin\" and \"Species\" for the second dataset are inferred based on common practices in such studies.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5745, "completion_tokens": 521, "total_tokens": 6266, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcf812c81908a23841cb4aef62a", "custom_id": "syn26238842", "response": {"status_code": 200, "request_id": "3317826a9695f9e28ddc461828c59eda", "body": {"id": "chatcmpl-BE49mCTX9lrISlqqxdfg0cJN7bTTk", "object": "chat.completion", "created": 1742692270, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the provided information, here is the curated dataset metadata in accordance with the JSON schema:\n\n```json\n[\n  {\n    \"title\": \"Trial Run HscWT and Hsc45 Proteomics\",\n    \"creator\": \"Isabelle Logan\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"proteomics\",\n      \"trial run\",\n      \"NF2\",\n      \"nitrated proteins\",\n      \"HscWT\",\n      \"Hsc45\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn26238842\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"Proteomics Trial Data for NF2\",\n    \"description\": \"Proteomics data from a trial run exploring the role of nitrated proteins in NF2. Focuses on HscWT and Hsc45.\",\n    \"creator\": \"Isabelle Logan\",\n    \"contributor\": [\n      \"Maria C. Franco\",\n      \"Isabelle E. Logan\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"institution\": [\n      \"Oregon State University\",\n      \"University of Central Florida\"\n    ],\n    \"conditionsOfAccess\": \"Additional registration or specific authentication methods may be required.\",\n    \"measurementTechnique\": \"Mass spectrometry\",\n    \"series\": \"NF-OSI Processed Data\",\n    \"yearProcessed\": 2023\n  }\n]\n```\n\n### Notes:\n- Some fields like `individualCount`, `species`, and `specimenCount` remain unknown as the data was not provided.\n- The `series` and `yearProcessed` fields are included based on assumptions from typical dataset requirements. If not applicable, you may need to remove them or provide specifics.\n- The `license` is set to \"UNKNOWN\" since no specific license information was provided.\n- Measurement Technique was assumed to be \"Mass spectrometry\" based on the context of proteomics, though it should be properly verified.\n- AccessType was assumed to be \"Controlled Access\" given the nature of typical scientific datasets involving sensitive or unpublished data. Adjust as necessary with more data context.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4676, "completion_tokens": 482, "total_tokens": 5158, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcf91048190b76f5a82d6f7d02a", "custom_id": "syn11374354", "response": {"status_code": 200, "request_id": "71fb790dcb332b21678602ec38750728", "body": {"id": "chatcmpl-BE49lpRdFTUwKFhAotT0MWkFs5iQs", "object": "chat.completion", "created": 1742692269, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Using the provided information, here is the curated metadata for each dataset formatted in accordance with the JSON schema provided:\n\n```json\n[\n  {\n    \"title\": \"12 months deliverable\",\n    \"creator\": \"Alice Soragni\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"immunohistochemistry\", \"Homo sapiens\", \"Neurofibromatosis type 1\", \"Cutaneous Neurofibroma\", \"image\"],\n    \"dataType\": [\"image\"],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"A collection of images from immunohistochemistry assays on cutaneous neurofibroma specimens. The dataset supports drug screening efforts by characterizing the tumor environment.\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"manifestation\": [\"Cutaneous Neurofibroma\"],\n    \"measurementTechnique\": [\"immunohistochemistry\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"specimenCount\": 76,\n    \"contributor\": [\"Alice Soragni\"],\n    \"visualizeDataOn\": [\"http://nfdataportal.org\"]\n  },\n  {\n    \"title\": \"6 month deliverables\",\n    \"creator\": \"Alice Soragni\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"immunohistochemistry\", \"Homo sapiens\", \"Neurofibromatosis type 1\", \"Cutaneous Neurofibroma\", \"image\"],\n    \"dataType\": [\"image\"],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Documents detailing immunohistochemistry protocols and images related to cNF research, aimed at establishing effective drug screening protocols.\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"manifestation\": [\"Cutaneous Neurofibroma\"],\n    \"measurementTechnique\": [\"immunohistochemistry\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 1,\n    \"specimenCount\": 2,\n    \"contributor\": [\"Alice Soragni\"],\n    \"visualizeDataOn\": [\"http://nfdataportal.org\"]\n  },\n  {\n    \"title\": \"Aligned reads from RNA-seq of cutaneous neurofibroma organoid model\",\n    \"creator\": \"Orca Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"Homo sapiens\", \"AlignedReads\", \"Neurofibromatosis type 1\", \"Cutaneous Neurofibroma\"],\n    \"dataType\": [\"dataIndex\", \"AlignedReads\"],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"RNA-seq data featuring aligned reads for cutaneous neurofibroma organoids facilitating research into tumor genetics.\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"manifestation\": [\"Cutaneous Neurofibroma\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 54,\n    \"contributor\": [\"Orca Service\"],\n    \"visualizeDataOn\": [\"http://nfdataportal.org\"]\n  },\n  {\n    \"title\": \"Gene expression quantification of cutaneous neurofibroma organoid model\",\n    \"creator\": \"Orca Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"Homo sapiens\", \"geneExpression\", \"Neurofibromatosis type 1\", \"Cutaneous Neurofibroma\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Quantified gene expression from RNA-seq data of cutaneous neurofibroma organoid model for advancing research in cellular heterogeneity.\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"manifestation\": [\"Cutaneous Neurofibroma\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 55,\n    \"contributor\": [\"Orca Service\"],\n    \"visualizeDataOn\": [\"http://nfdataportal.org\"]\n  },\n  {\n    \"title\": \"NF Organoid Bisulfite-seq\",\n    \"creator\": \"Unknown\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"bisulfite sequencing\", \"Homo sapiens\", \"chromatinActivity\", \"Neurofibromatosis type 1\", \"Cutaneous Neurofibroma\"],\n    \"dataType\": [\"chromatinActivity\"],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Bisulfite sequencing data to examine chromatin activity in NF organoids, pivotal for studying epigenetic modifications.\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"manifestation\": [\"Cutaneous Neurofibroma\"],\n    \"measurementTechnique\": [\"bisulfite sequencing\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 55,\n    \"contributor\": [\"Unknown\"],\n    \"visualizeDataOn\": [\"http://nfdataportal.org\"]\n  },\n  {\n    \"title\": \"NF Organoid RNA-seq\",\n    \"creator\": \"Unknown\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"Homo sapiens\", \"geneExpression\", \"Neurofibromatosis type 1\", \"Cutaneous Neurofibroma\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"High-throughput RNA-seq of NF organoids providing insight into the gene expression landscape of cutaneous neurofibromas.\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"manifestation\": [\"Cutaneous Neurofibroma\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 57,\n    \"contributor\": [\"Unknown\"],\n    \"visualizeDataOn\": [\"http://nfdataportal.org\"]\n  },\n  {\n    \"title\": \"NFOSI-RNASeq-To-Process-2023-14-03\",\n    \"creator\": \"Alice Soragni\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"Homo sapiens\", \"geneExpression\", \"Neurofibromatosis type 1\", \"Cutaneous Neurofibroma\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Processing raw RNA-seq data of NF organoids to prepare them for detailed gene expression analysis.\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"manifestation\": [\"Cutaneous Neurofibroma\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 57,\n    \"contributor\": [\"Alice Soragni\"],\n    \"visualizeDataOn\": [\"http://nfdataportal.org\"]\n  },\n  {\n    \"title\": \"RNASeq - Failed QC\",\n    \"creator\": \"Alice Soragni, Sara Gosline\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"quality control\", \"Homo sapiens\", \"Neurofibromatosis type 1\", \"geneExpression\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"RNASeq data that did not meet quality control standards, for insights into potential errors in sample processing or data handling.\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"manifestation\": [\"Cutaneous Neurofibroma\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 2,\n    \"specimenCount\": 6,\n    \"contributor\": [\"Alice Soragni\", \"Sara Gosline\"],\n    \"visualizeDataOn\": [\"http://nfdataportal.org\"]\n  }\n]\n```\n\nThis metadata is structured as per the JSON schema, capturing essential details like title, creator, and data specifics for each dataset within the project.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 6165, "completion_tokens": 2057, "total_tokens": 8222, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcfa1f481909f0ed68c2b6a0329", "custom_id": "syn28545963", "response": {"status_code": 200, "request_id": "a59560217d1cf60bdc9a5180d93791f5", "body": {"id": "chatcmpl-BE49nJaVEOn6a3inhZ6bs53jjTLhD", "object": "chat.completion", "created": 1742692271, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the project and table summaries provided, here is the curated metadata for the datasets:\n\n```json\n[\n  {\n    \"title\": \"Viral Counts (CTAT-VIF)\",\n    \"creator\": \"Robert Allaway\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"Viral Counts\",\n      \"Genomics\",\n      \"Virus Detection\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn28545963\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NEC\",\n      \"SMARCB1-related schwannomatosis\",\n      \"LZTR1-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"This dataset contains viral read count summaries from VirusDetect assays conducted on schwannomatosis patient tumor samples. Data were created by Robert Allaway.\",\n    \"datePublished\": 2023,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"conditionsOfAccess\": \"Requires Synapse account, certification quiz, user profile completion, and request access with Terms and Conditions agreement.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"visualizeDataOn\": [\n      \"https://gitlab.com/nf-community/swnts\"\n    ],\n    \"individualCount\": null,\n    \"specimenCount\": null,\n    \"countryOfOrigin\": null,\n    \"species\": null,\n    \"manifestation\": [\n      \"Multiple\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"WES\",\n    \"creator\": \"\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Whole Exome Sequencing\",\n      \"Genomics\",\n      \"Schwannomatosis\",\n      \"WES\"\n    ],\n    \"dataType\": [\n      \"Whole Exome Sequencing\"\n    ],\n    \"studyId\": \"syn28545963\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NEC\",\n      \"SMARCB1-related schwannomatosis\",\n      \"LZTR1-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"This dataset contains whole exome sequencing data aimed at uncovering genomic variants and features related to schwannomatosis.\",\n    \"datePublished\": 2023,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"conditionsOfAccess\": \"Requires Synapse account, certification quiz, user profile completion, and request access with Terms and Conditions agreement.\",\n    \"measurementTechnique\": [\n      \"Whole Exome Sequencing\"\n    ],\n    \"visualizeDataOn\": [\n      \"https://gitlab.com/nf-community/swnts\"\n    ],\n    \"individualCount\": null,\n    \"specimenCount\": null,\n    \"countryOfOrigin\": null,\n    \"species\": null,\n    \"manifestation\": [\n      \"Multiple\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```\n\n### Notes\n- Where information is missing in the summaries, such as specific counts and species origin, fields are left null, following the schema guidelines to omit if not applicable/unknown.\n- Access and conditions of access were set to \"Controlled Access\" based on the requirements outlined for dataset access, including registration and terms acceptance.\n- Keywords, disease focus, funder, and measurement techniques were derived from project goals and context provided, aligned with available data from Schwannomatosis Open Research Collaborative objectives.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5701, "completion_tokens": 800, "total_tokens": 6501, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcfb2448190b331482ca1e2656d", "custom_id": "syn4939892", "response": {"status_code": 200, "request_id": "ed2c4c77d3a03fbdfbe191d3cfa6ef60", "body": {"id": "chatcmpl-BE49mndVbYq17iooVGOYleIZSKqq8", "object": "chat.completion", "created": 1742692270, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the information provided, here is the curated JSON metadata for the dataset:\n\n```json\n[\n  {\n    \"title\": \"Gene Expression for Identification of Neurofibroma Growth and Drug Resistance Pathways\",\n    \"creator\": \"Kwangmn Choi\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis\",\n      \"Plexiform Neurofibroma\",\n      \"Gene Expression\",\n      \"RNA-seq\",\n      \"Drug Resistance\",\n      \"Mouse Models\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939892\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Nancy Ratner, Ph.D.\",\n      \"Kwangmn Choi\"\n    ],\n    \"countryOfOrigin\": [\"Unknown\"],\n    \"description\": \"This dataset contains gene expression data from mouse models used to identify molecular pathways correlating with neurofibroma growth and drug resistance, focusing on slow- vs fast-growing tumors and response to therapies.\",\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"individualCount\": 2,\n    \"specimenCount\": 2,\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"datePublished\": 2014,\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```\n\nThis JSON metadata incorporates all the relevant information provided, ensuring completeness and conformity with the given schema.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4973, "completion_tokens": 396, "total_tokens": 5369, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcfc4c481908b73fcd3cb1a9056", "custom_id": "syn51133946", "response": {"status_code": 200, "request_id": "b7b4f6914d5dd398ee01baf5209397b9", "body": {"id": "chatcmpl-BE49tuituci2bJeUupZ1T2ZgtuSYl", "object": "chat.completion", "created": 1742692277, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Based on the provided information, here's the metadata for the dataset according to the given JSON schema:\n\n```json\n[\n  {\n    \"title\": \"ADVL1521 Omic Data Repository\",\n    \"creator\": \"Kevin Shannon, Mignon Loh\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"JMML\",\n      \"RNA-seq\",\n      \"Hematopoietic Neoplasm\",\n      \"Ras Signaling\",\n      \"Gene Expression\",\n      \"Trametinib\",\n      \"MEK Inhibitor\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn51133946\",\n    \"diseaseFocus\": [\n      \"Juvenile Myelomonocytic Leukemia (JMML)\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\"\n    ],\n    \"description\": \"This dataset contains single-cell RNA-seq data from juvenile myelomonocytic leukemia (JMML) patients, focusing on gene expression profiling. The study investigates the impact of MEK inhibitors on JMML, highlighting the modulation of mutant bone marrow cells' proliferation and differentiation.\",\n    \"contributor\": [\n      \"University of California, San Francisco\"\n    ],\n    \"countryOfOrigin\": [\n      \"United States\"\n    ],\n    \"datePublished\": 2023,\n    \"individualCount\": 7,\n    \"specimenCount\": 14,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"single-cell RNA-seq\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```\n\n### Key Points:\n- **Creator** and **Contributor** are inferred from project leadership and institution.\n- Assumed **Controlled Access** given the specialized nature of clinical data.\n- Descriptions, keywords, and disease focus are tailored to the project details.\n- **Country of Origin** is based on the institution's location.\n- **Date Published** is set to 2023, considering recent data availability.\n- **Measurement Technique** includes single-cell RNA-seq based on assay information.\n- Existing data are included in the Synapse data catalog.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4730, "completion_tokens": 468, "total_tokens": 5198, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
{"id": "batch_req_67df5fcfd9108190b22e9b5fa700f5d6", "custom_id": "syn4939918", "response": {"status_code": 200, "request_id": "07e6abce4e511a904669be6b8756f8d7", "body": {"id": "chatcmpl-BE49n0s2cgN8xVvSJiihTeTSYyuF5", "object": "chat.completion", "created": 1742692271, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Here is the curated metadata for each of the datasets:\n\n```json\n[\n  {\n    \"title\": \"Gene Expression Quantification from RNA-seq\",\n    \"creator\": \"NF Service\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"Quantification\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939918\",\n    \"diseaseFocus\": [\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"alternateName\": \"RNA-seq Gene Expression Data\",\n    \"contributor\": [\n      \"NF Service\"\n    ],\n    \"datePublished\": 2022,\n    \"description\": \"This dataset contains gene expression quantification data obtained from RNA-seq assays, facilitating insights into differential gene expression associated with specific conditions.\",\n    \"individualCount\": 4,\n    \"specimenCount\": 27,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"measurementTechnique\": \"RNA-seq\"\n  },\n  {\n    \"title\": \"MethylationArray\",\n    \"creator\": \"Bernat Gel Moreno\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Methylation\",\n      \"Array\",\n      \"Chromatin Activity\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn4939918\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"alternateName\": \"Methylation Array Data\",\n    \"contributor\": [\n      \"Bernat Gel Moreno\",\n      \"Kaitlin Throgmorton\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"Contains data from methylation arrays, used to study chromatin activity in neurofibromatosis type 1 samples.\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"measurementTechnique\": \"methylation array\"\n  },\n  {\n    \"title\": \"NFOSI-RNASeq-To-Process-2023-14-03\",\n    \"creator\": \"Bernat Gel Moreno\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Gene Expression\",\n      \"RNA-seq\",\n      \"Processing\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939918\",\n    \"diseaseFocus\": [\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"alternateName\": \"RNASeq Data Processing\",\n    \"contributor\": [\n      \"Bernat Gel Moreno\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"Contains RNA-seq gene expression data to be processed for further analysis and insights into multiple conditions.\",\n    \"individualCount\": 4,\n    \"specimenCount\": 27,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"measurementTechnique\": \"RNA-seq\"\n  },\n  {\n    \"title\": \"RNAseq\",\n    \"creator\": \"Bernat Gel Moreno\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Gene Expression\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939918\",\n    \"diseaseFocus\": [\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"alternateName\": \"Homo sapiens RNAseq\",\n    \"contributor\": [\n      \"Bernat Gel Moreno\",\n      \"Christina Parry\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"RNA-seq dataset capturing gene expression in Homo sapiens, focusing on various conditions and factors.\",\n    \"individualCount\": 4,\n    \"specimenCount\": 27,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"measurementTechnique\": \"RNA-seq\"\n  },\n  {\n    \"title\": \"SNParray\",\n    \"creator\": \"Bernat Gel Moreno\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"SNP\",\n      \"Array\",\n      \"Genomic Variants\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn4939918\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"alternateName\": \"SNP Genomic Array\",\n    \"contributor\": [\n      \"Bernat Gel Moreno\",\n      \"Kaitlin Throgmorton\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"Genomic variant data from SNP arrays in neurofibromatosis type 1 studies, enabling study of genetic associations.\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"measurementTechnique\": \"SNP array\"\n  }\n]\n``` \n\nIn creating the metadata, I ensured that each dataset contains the required fields and included additional fields where information was available. Since not all details were provided, some fields were left out according to the schema's guidelines.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5460, "completion_tokens": 1257, "total_tokens": 6717, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_90d33c15d4"}}, "error": null}
